Welcome to our dedicated page for Healthy Extracts news (Ticker: HYEX), a resource for investors and traders seeking the latest updates and insights on Healthy Extracts stock.
Healthy Extracts Inc. (OTCQB: HYEX) generates frequent news as a science-based nutraceutical and oral delivery technology company focused on heart, brain, gut and metabolic health. Company updates often highlight record quarterly net revenue, growth in subscription-based recurring revenue, and developments in its proprietary delivery platforms.
News coverage for HYEX commonly includes earnings and outlook announcements, such as record net revenue quarters and revised annual guidance, as well as details on adjusted EBITDA and cash flow trends. Releases also describe operational milestones, including maintaining a top-three category ranking on Amazon.com for certain products and expanding direct-to-consumer and retail channels.
Another major theme in Healthy Extracts news is corporate transactions and integration. The acquisition and merger of Gummy USA, a precision-dosed nutraceutical gummy manufacturer with a HACCP, GMP-certified and FDA-registered facility, has been covered in detail, including the associated change-of-control events disclosed in Form 8-K filings. Updates describe how this transaction adds in-house manufacturing, SureDose™ technology and new white-label and private-label customers.
Product and technology launches are also frequent topics. Recent releases have introduced STAT10 for statin users, 4Sleep for sleep support, Hydrate EZ™ and Mynus Sugar™ gel-packs using Gelteq technology, and the Whitney Johns Gut Health Straw™ based on functional fiber straw IP. These stories explain how new formulations and delivery systems expand Healthy Extracts’ addressable markets and support its growth roadmap.
Investors following HYEX news can expect coverage of financial performance, mergers and acquisitions, new product categories, white-label wins, and conference presentations at microcap and growth-focused investor events. Bookmark this page to monitor how recurring revenue, exclusive technologies and strategic partnerships shape the company’s ongoing narrative.
Healthy Extracts Inc. (OTCQB: HYEX) announced the launch of brand influencer Whitney Johns' new line of health and fitness products. The line includes brain health, physical performance, and hormone support supplements, all based on Healthy Extracts' proprietary formulations. The products are vegan, non-GMO, gluten-free, and supported by extensive clinical research. This initiative aims to enhance sales channels and bolster brand identity, leveraging Johns' significant social media following to reach broader audiences.
Healthy Extracts Inc. (OTCQB: HYEX) reported preliminary Q1 results for 2022, estimating net revenue over $489,000, a 187% increase year-over-year. This growth is attributed to direct-to-consumer channel expansion and a four-fold rise in subscription revenue. The company anticipates its first positive net income quarter, maintaining its 2022 forecast of over $3 million in revenue. Healthy Extracts has focused on building a foundation in the brain and heart health markets through acquisitions and clinical studies, aiming for 100% sales growth this year.
Healthy Extracts Inc. (OTCQB: HYEX) reported strong fourth quarter and full year results for 2021, showcasing a net revenue of $672,000 in Q4, up 77% sequentially and 394% year-over-year. The company reversed its previous net loss, achieving a net income of $535,000. Annual revenue increased 15% to a record $1.5 million, with gross profit at $695,000, representing 47.4% of net revenue. Healthy Extracts launched innovative nutraceuticals, including Ultimate Brain Nutrients™, and engaged brand influencer Whitney Johns to boost market presence.
Healthy Extracts Inc. (OTCQB: HYEX) has launched an educational initiative on its YouTube channel to promote its clinically proven plant-based products for heart and brain health. The channel will feature informative content, including interviews with founders and product development teams, as well as influencers like Whitney Johns. The company recently published strong clinical trial results for its product UBN RELIEF, demonstrating significant benefits for migraine sufferers and cognitive function. With 100+ clinical studies backing its formulations, Healthy Extracts aims for over 100% sales growth in 2022.
Healthy Extracts Inc. (OTCQB: HYEX) has announced over 100% sales growth for 2022, driven by its innovative, clinically proven plant-based products targeting brain and heart health. The company's Ultimate Brain Nutrients™ and Citrus Bergamot SuperFruit™ formulations are positioned in rapidly expanding markets, with brain health projected to reach $24.6 billion and heart health $24.8 billion by 2027. Healthy Extracts launched new products and received follow-on orders from distributors, expecting continued growth with revenue estimated at $1.7 million for 2021, marking a 31% increase.
Healthy Extracts Inc. (OTCQB: HYEX) has announced significant results from a prospective, randomized, double-blind, placebo-controlled trial of UBN RELIEF™, a formulation aimed at alleviating migraine symptoms. The 60-day study showed a 53% reduction in migraine incidents, 39% decrease in duration, and 27% less pain severity. Additionally, participants reported a 43% improvement in quality of life and a 55% reduction in time lost due to migraines. No adverse side effects were noted, highlighting its potential as a safe alternative for the millions suffering from migraines.
Healthy Extracts Inc. (HYEX) has extended its exclusive marketing contract for Citrus Bergamot SuperFruit™ with Herbal & Antioxidant Derivatives, S.r.l. until December 31, 2023. This contract gives Healthy Extracts a competitive edge, allowing them to distribute the highest strength Citrus Bergamot with 47% BPF potency, surpassing competitors’ 38% BPF. The company anticipates at least 100% organic revenue growth for 2022, with predicted gross revenues reaching approximately $1.7 million, a 31% increase year-over-year. The heart-health supplement market is projected to grow significantly, reaching $24.8 billion by 2027.
Healthy Extracts (OTCQB: HYEX) reported strong preliminary results for Q4 and full year 2021. Q4 gross revenue is expected to be around $770,000, a 72% sequential increase and over 519% year-over-year. Full year revenue is projected at $1.7 million, up 31%. The company highlights a growing customer base with a lifetime value exceeding $500. Key developments include two new high-potency formulations leveraging Citrus Bergamot SuperFruit™, aiming for 100% organic revenue growth in 2022. Healthy Extracts plans to release full year results by March end.
Healthy Extracts Inc. (OTCQB: HYEX) has appointed J. Scott Landers as executive vice president of sales and marketing. Landers brings over 20 years of experience from notable companies like KPMG and IBM, focusing on product launches and revenue growth. He expressed enthusiasm about joining the company during a pivotal growth stage and aims to expand distribution channels and product offerings. President Duke Pitts anticipates Landers’ expertise will drive sales growth and enhance market reach, particularly in B2B distribution and subscription-based offerings.
FAQ
What is the current stock price of Healthy Extracts (HYEX)?
What is the market cap of Healthy Extracts (HYEX)?
